184TiPFIND: A phase II study to evaluate the efficacy of...

Annals of Oncology 2019 / 04 Vol. 30; Iss. Supplement

184TiPFIND: A phase II study to evaluate the efficacy of erdafitinib in FGFR-altered squamous NSCLC

Nogova, L, Malchers, F, Hillmer, A, Merkelbach-Bruse, S, Pinto, A, Woempner, C, Riedel, R, Scheffler, M, Michels, S, Porre, P De, Santiago-Walker, A, Fischer, R N, Abdulla, D S, Thomas, R, Buettner, R
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz063.082
Date:
April, 2019
File:
PDF, 79 KB
2019
Conversion to is in progress
Conversion to is failed